Ahmed Vachiat

Ahmed Vachiat

Auto-generated profile, based on publicly available information

Ahmed Vachiat

Division of Cardiology, Department of Internal Medicine, Faculty of Health Sciences University of the Witwatersrand Johannesburg South Africa

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2020 in Nephron
Verified
Journal Article
Closed access
PDF file
MHMuzamil Olamide Hassan
Muzamil Olamide Hassan
RDRaquel Duarte
Raquel Duarte
CDCaroline Dickens
Caroline Dickens
TDTherese Dix-Peek
Therese Dix-Peek
SNSagren Naidoo
Sagren Naidoo
SNSaraladevi Naicker
Saraladevi Naicker
Introduction: Apolipoprotein L1 (APOL1) plays an important role in cholesterol metabolism and attenuation of low-density lipoprotein (LDL) oxidation. While protecting against Trypanosoma brucei rhodesiense infection, APOL1 risk alleles confer greater risk for CKD and cardiovascular disease among patients of African descent. Objectives: We investigated whether APOL1 risk variants are associated with atherosclerosis and oxidized LDL (OxLDL) levels among black South African CKD patients. Methods: A cross-sectional study of 120 adult CKD patients and 40 controls was undertaken. DNA samples of participants were genotyped for APOL1 G1 and G2 variants. High-sensitivity C-reactive protein, serum lipids, and OxLDL levels were measured, and carotid doppler ultrasonography was performed on all participants. Results: APOL1 alleles rs73885319, rs60910145, and rs71785313 had minor allele frequencies of 9.2, 8.8, and 17.5%, respectively, in the patients, and 8.8, 8.8, and 13.8%, respectively, in the controls. Of the 9 patients with 2 APOL1 risk alleles, 77.8% were compound G1/G2 heterozygotes and 22.2% were G2 homozygotes. Carriers of at least 1 APOL1 risk allele had a 3-fold increased risk of subclinical atherosclerosis (odds ratio 3.19; 95% confidence interval: 1.64–6.19; p = 0.01) compared to individuals with no risk alleles. Patients with 1 or 2 APOL1 risk alleles showed a significant increase in OxLDL levels when compared with those without the APOL1 risk allele. Conclusion: These findings suggest an increased risk for atherosclerosis in carriers of a single APOL1 risk variant, and the presence of APOL1 risk variants was associated with increased serum OxLDL levels in black South African CKD patients.

1 February 2018 in Cardiology Clinics
Verified
Journal Article
Closed access
Nqoba TsabedzeNqoba Tsabedze
Nqoba Tsabedze
AVAhmed Vachiat
Ahmed Vachiat
DZDon Zachariah
Don Zachariah
PMPravin Manga
Pravin Manga

1 January 2020 in Wits Journal of Clinical Medicine
Verified
Journal Article
Open access
KMKeir McCutcheon
Keir McCutcheon
Nqoba TsabedzeNqoba Tsabedze
Nqoba Tsabedze
AVAhmed Vachiat
Ahmed Vachiat
DZDon Zachariah
Don Zachariah
PMPravin Manga
Pravin Manga
More than 35 million cases and 1 million deaths due to coronavirus disease 2019 (COVID-19) have been reported to date, with case-fatality rates ranging from 2.3% to 7.3%. COVID-19 is caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which is related to SARS-CoV-1 and Middle East Respiratory Syndrome (MERS) coronaviruses, which have both caused pandemics in the last 20 years. Similar to SARS-CoV-1 and MERS, SARS-CoV-2 primarily affects the respiratory system. However, it has become evident that COVID-19 is a multisystem infection leading to a variety of symptoms and clinical presentations. Amongst these, COVID-19 has also been associated with a range of cardiovascular system (CVS) manifestations with its attendant morbidity and mortality. Overall, several studies have demonstrated an increased incidence of elevated cardiac troponins, myocardial injury, acute coronary syndromes (ACSs), coagulopathy and cardiac arrhythmia in patients with COVID-19. Furthermore, underlying CVS comorbidities have been found to be important in outcomes among patients infected with SARS-CoV-2. The aim of this review is to summarise the important links between COVID- 19 and the CVS, highlighting currently recommended interventions to improve patient outcomes.

1 March 2023 in Southern African Journal of Anaesthesia and Analgesia
Verified
Journal Article
Open access
TCT Chitagu
T Chitagu
BBB Bobat
B Bobat
AVA Vachiat
A Vachiat
JFJune Fabian
June Fabian
LBL Brannigan
L Brannigan

9 April 2026 in Clinical Case Reports
Verified
Journal Article
Open access
AMAkshay Manga
Akshay Manga
AVAhmed Vachiat
Ahmed Vachiat
Exercise‐induced left bundle branch block (EI‐LBBB) is a rare phenomenon, particularly in patients without structural heart disease. Its pathophysiology remains poorly understood and there are no defined treatment protocols. We report a 77‐year‐old man with a history of syncope who developed EI‐LBBB during a cardiac stress test, with transient electrocardiographic changes that resolved at rest. Coronary angiography revealed only a mild–moderate (approximately 25%–50%) proximal left anterior descending artery stenosis, and the rest of his cardiac evaluation was unremarkable. The patient was commenced on an aerobic exercise program, and reported symptomatic improvement on follow‐up. Although EI‐LBBB is often linked to underlying structural heart disease and coronary artery disease, it can occur in patients with normal cardiac structure. This report summarizes an approach to evaluation and follow‐up of EI‐LBBB and reviews management strategies described in the literature, including exercise training in selected patients.